According to Due Diligence Score, the 3 best healthcare plan stocks to buy right now are:
1. Molina Healthcare (NYSE:MOH)
Molina Healthcare (NYSE:MOH) is the top healthcare plan stock with a Due Diligence Score of 65, which is 23 points higher than the healthcare plan industry average of 42. It passed 22 out of 33 due diligence checks and has strong fundamentals. Molina Healthcare has seen its stock lose -19.22% over the past year, underperforming other healthcare plan stocks by -6 percentage points.
Molina Healthcare has an average 1 year
price target of $353.90, an upside of 18.98% from Molina Healthcare's current stock price of $297.44.
Molina Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Molina Healthcare, 30% have issued a Strong Buy rating, 10% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Elevance Health (NYSE:ELV)
Elevance Health (NYSE:ELV) is the second best healthcare plan stock with a Due Diligence Score of 56, which is 14 points higher than the healthcare plan industry average of 42. It passed 20 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock lose -17.51% over the past year, underperforming other healthcare plan stocks by -4 percentage points.
Elevance Health has an average 1 year
price target of $514.90, an upside of 32.29% from Elevance Health's current stock price of $389.22.
Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Elevance Health, 80% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Centene (NYSE:CNC)
Centene (NYSE:CNC) is the third best healthcare plan stock with a Due Diligence Score of 49, which is 7 points higher than the healthcare plan industry average of 42. It passed 16 out of 33 due diligence checks and has strong fundamentals. Centene has seen its stock lose -15.31% over the past year, underperforming other healthcare plan stocks by -2 percentage points.
Centene has an average 1 year
price target of $80.92, an upside of 27.12% from Centene's current stock price of $63.66.
Centene stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Centene, 53.85% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a hold, while 7.69% have issued a Sell rating, and 0% have issued a Strong Sell.